Hundreds of clinics pushing unproven stem cell procedures caught a big break from the U.S. government in 2017: They would have three years to show that their questionable treatments were safe and worked before regulators ...
Sep 30, 2021
0
2
A review by the GLUTEN3S research group at the UPV/EHU-University of the Basque Country describes the nutritional imbalances found in adults suffering from celiac disease who follow a gluten-free diet. The keys to avoiding ...
Sep 27, 2021
0
5
The European Union recommended Monday that its 27 nations reinstate restrictions on tourists from the U.S. because of rising coronavirus infections there, but member countries will keep the option of allowing fully vaccinated ...
Aug 30, 2021
0
111
Biogen Inc. fought back against criticism of the unusual circumstances that led to the U.S. approval of its Alzheimer's drug Aduhelm, saying in an open letter it has been the subject of "extensive misinformation and misunderstanding."
Jul 22, 2021
0
1
Pfizer's COVID-19 vaccine is entering the final phase of review before the U.S. government decides whether to allow millions to get the shots.
Dec 8, 2020
0
2
(HealthDay)—Two COVID-19 vaccines are on the verge of approval in the United States, with pharmaceutical companies promising that millions of doses will be available to the first wave of recipients within a matter of weeks.
Dec 4, 2020
0
8
Hydroxychloroquine, double-blind studies, convalescent plasma, herd immunity—the coronavirus pandemic has thrust the language of science into public view as never before.
May 19, 2020
0
1
A review of recent clinical trials paints a sobering picture of the usefulness of first-line psychotherapies in treating active duty military personnel and veterans with Post-Traumatic Stress Disorder (PTSD).
Feb 3, 2020
0
7
While we expect to see scientists publishing in journals aimed at peers, a pair of Western researchers recently targeted a younger audience for their work—a lot younger.
Jul 12, 2019
0
41
(HealthDay)—A U.S. Food and Drug Administration advisory panel vote on whether to recommend approval of the first oral medication for type 1 diabetes ended in an 8-8 tie Thursday.
Jan 18, 2019
0
6
